分层医学时代的肺纤维化
本文综述了肺纤维化的遗传结构,常见变异(如MUC5B rs35705950)与罕见变异共同参与发病。常见变异聚合可解释约三分之一的IPF风险,罕见变异涉及端粒维护与表面活性物质代谢两条通路,后者多预测蛋白错误折叠所致毒性功能获得。英国10万基因组计划有望推动常见与罕见变异的诊断与预后价值研究。
要点
- MUC5B rs35705950是肺纤维化中最广泛复现的常见变异,与IPF和家族性间质性肺炎强关联。
- 常见变异聚合可解释约三分之一的IPF风险,部分常见变异具有预后潜力。
- 罕见变异涉及端粒维护与表面活性物质代谢两条通路,效应量高于常见变异。
核心结论
- 常见与罕见变异共同构成肺纤维化的遗传结构,罕见变异机制可能适用于更广泛的患者群体。
研究设计与样本
- 综述,总结全基因组关联研究与全外显子测序等遗传学研究证据。
主要发现
- MUC5B启动子区变异rs35705950在多个队列中与IPF和家族性间质性肺炎强关联。
- 常见变异聚合可解释约三分之一的IPF风险。
- 端粒相关基因杂合罕见变异与成人起病肺纤维化共分离,外显率不全,导致蛋白功能降低并伴端粒缩短。
- 不同端粒基因致病罕见变异相关肺纤维化呈进展性且生存特征相似。
- 表面活性物质基因杂合罕见变异多预测蛋白错误折叠所致毒性功能获得和内质网应激增加。
关键数值与推荐
- 常见变异定义为次要等位基因频率>5%。
- 散发性IPF患者中可见端粒缩短与内质网应激增加的证据。
临床怎么用
- 对肺纤维化患者可关注遗传变异信息以辅助诊断与预后判断。
- 端粒相关基因变异相关肺纤维化需认识到其进展性与相似生存特征。
局限性
- 基因型-表型相关性较差。
- 罕见变异相关结论部分来自独特个体与家系研究,推广至更广泛人群需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Both common and rare variants contribute to the genetic architecture of pulmonary fibrosis. Genome-wide association studies have identified common variants, or those with a minor allele frequency of >5%, that are linked to pulmonary fibrosis. The most widely replicated variant (rs35705950) is located in the promoter region of the MUC5B gene and has been strongly associated with idiopathic pulmonary fibrosis (IPF) and familial interstitial pneumonia (FIP) across multiple different cohorts. However, many more common variants have been identified with disease risk and in aggregate account for approximately one-third of the risk of IPF. Moreover, several of these common variants appear to have prognostic potential. Next generation sequencing technologies have facilitated the identification of rare variants. Recent whole exome sequencing studies have linked pathogenic rare variants in multiple new genes to FIP. Compared with common variants, rare variants have lower population allele frequencies and higher effect sizes. Pulmonary fibrosis rare variants genes can be subdivided into two pathways: telomere maintenance and surfactant metabolism. Heterozygous rare variants in telomere-related genes co-segregate with adult-onset pulmonary fibrosis with incomplete penetrance, lead to reduced protein function, and are associated with short telomere lengths. Despite poor genotype-phenotype correlations, lung fibrosis associated with pathogenic rare variants in different telomere genes is progressive and displays similar survival characteristics. In contrast, many of the heterozygous rare variants in the surfactant genes predict a gain of toxic function from protein misfolding and increased endoplasmic reticulum (ER) stress. Evidence of both telomere shortening and increased ER stress have been found in sporadic IPF patients, suggesting that the mechanisms identified from rare variant genetic studies in unique individuals and families are applicable to a wider spectrum of patients. The ability to sequence large cohorts of individuals rapidly has the potential to further our understanding of the relative contributions of common and rare variants in the pathogenesis of pulmonary fibrosis. The UK 100,000 Genomes Project will provide opportunities to interrogate both common and rare variants and to investigate how these biological signals provide diagnostic and prognostic information in the era of stratified medicine.
引用
- Mathai SK, Newton CA, Schwartz DA, et al. Pulmonary fibrosis in the era of stratified medicine. Thorax. 2016. PMID: 27799632. doi:10.1136/thoraxjnl-2016-209172
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。